Article
An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma.
Frontiers in immunology - 1 Jan 2021
Wang Xinwen, Wu Shouwu, Liu Feng, Ke Dianshan, Wang Xinwu, Pan Dinglong, Xu Weifeng, Zhou Ling, He Weidong
Abstract excerpt
Immunogenic cell death (ICD) has been classified as a form of regulated cell death (RCD) that is sufficient to activate an adaptive immune response. Accumulating evidence has demonstrated the ability of ICD to reshape the tumor immune microenvironment through the emission of danger signals or DAMPs, which may contribute to the immunotherapy. Currently, identification of ICD-associated biomarkers that stratify...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
